Carbonic anhydrases: novel therapeutic applications for inhibitors and activators

被引：2698

作者：

Supuran, Claudiu T. ^{[1
]}

机构：

[1] Univ Florence, Chim Bioorgan Lab, I-50019 Florence, Italy

来源：

NATURE REVIEWS DRUG DISCOVERY | 2008年 / 7卷 / 02期

关键词：

D O I：

10.1038/nrd2467

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Carbonic anhydrases (CAs), a group of ubiquitously expressed metalloenzymes, are involved in numerous physiological and pathological processes, including gluconeogenesis, lipogenesis, ureagenesis, tumorigenicity and the growth and virulence of various pathogens. In addition to the established role of CA inhibitors (CAIs) as diuretics and antiglaucoma drugs, it has recently emerged that CAIs could have potential as novel anti-obesity, anticancer and anti-infective drugs. Furthermore, recent studies suggest that CA activation may provide a novel therapy for Alzheimer's disease. This article discusses the biological rationale for the novel uses of inhibitors or activators of CA activity in multiple diseases, and highlights progress in the development of specific modulators of the relevant CA isoforms, some of which are now being evaluated in clinical trials.

引用

页码：168 / 181

页数：14

共 121 条

[11] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide [J].

Cecchi, A ;

Winum, JY ;

Innocenti, A ;

Vullo, D ;

Montero, JL ;

Scozzafava, A ;

Supuran, CT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (23) :5775-5780

[12] Carbonic anhydrase inhibitors.: Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors [J].

Cecchi, A ;

Hulikova, A ;

Pastorek, J ;

Pastoreková, S ;

Scozzafava, A ;

Winum, JY ;

Montero, JL ;

Supuran, CT .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (15) :4834-4841

[13] Structure and function of carbonic anhydrases from Mycobacterium tuberculosis [J].

Covarrubias, AS ;

Larsson, AM ;

Högbom, M ;

Lindberg, J ;

Bergfors, T ;

Björkelid, C ;

Mowbray, SL ;

Unge, T ;

Jones, TA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :18782-18789

[14]

COX SN, 1988, ARCH OPHTHALMOL-CHIC, V106, P1190

[15] Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies [J].

De Simone, G ;

Di Fiore, A ;

Menchise, V ;

Pedone, C ;

Antel, J ;

Casini, A ;

Scozzafava, A ;

Wurl, M ;

Supuran, CT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) :2315-2320

[16] Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX [J].

De Simone, Giuseppina ;

Vitale, Rosa Maria ;

Di Fiore, Anna ;

Pedone, Carlo ;

Scozzafava, Andrea ;

Montero, Jean-Louis ;

Winum, Jean-Yves ;

Supuran, Claudiu T. .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (18) :5544-5551

[17] Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib [J].

Di Fiore, A ;

Pedone, C ;

D'Ambrosio, K ;

Scozzafava, A ;

De Simone, G ;

Supuran, CT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) :437-442

[18] Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: Proposal of a unified hypothesis [J].

Dorai, Thambi ;

Sawczuk, Ihor ;

Pastorek, Jaromir ;

Wiernik, Peter H. ;

Dutcher, Janice P. .

CANCER INVESTIGATION, 2006, 24 (08) :754-779

[19] Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors [J].

Dubois, Ludwig ;

Douma, Kim ;

Supuran, Claudiu T. ;

Chiu, Roland K. ;

van Zandvoort, Marc A. M. J. ;

Pastorekova, Silvia ;

Scozzafava, Andrea ;

Wouters, Braft G. ;

Lambin, Philippe .

RADIOTHERAPY AND ONCOLOGY, 2007, 83 (03) :367-373

[20] Zonisamide for weight loss in obese adults - A randomized controlled trial [J].

Gadde, KM ;

Franciscy, DM ;

Wagner, HR ;

Krishnan, KRR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1820-1825

← 1 2 3 4 5 6 7 8 9 10 →